Withdrawing from the treatment does not mean from the study.

C Bulletin of the World Health Organization | October 2008, 86 (10) Cheung 10. YB, Zaman SM, Ruopuro ML, Enwere G, Adegbola RA, Greenwood B, et al. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health 2008;13:603-11. PMID:18331385 Direct 11. and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease — United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005;54:893-7. PMID:16163262 Grijalva 12. CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369:1179-86. PMID:17416262 doi:10.1016/ S0140-6736(07)60564-9 Black 13. SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21:810-5. PMID:12352800 doi:10.1097/00006454-200209000-00005 Cutts 14. FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of ninevalent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46. PMID:15794968 doi:10.1016/ S0140-6736(05)71876-6 Klugman 15. KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8. PMID:14523142 doi:10.1056/NEJMoa035060 Pneumococcal conjugate vaccine for 16. childhood immunization – WHO position paper. Wkly Epidemiol Rec 2007;82:93-104. PMID:17380597